MedTrace Logo

Acute Coronary Syndrome and Acupressure

NCT06300294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-05-22

No results posted yet for this study

Summary

This study aims to examine the effect of acupressure on physiological parameters and anxiety levels in individuals diagnosed with Acute Coronary Syndrome (ACS).

H1-1: Acupressure applied to individuals with ACS has an effect on blood pressure.

H1-2: Acupressure applied to individuals with ACS has an effect on heart rate. H1-3: Acupressure applied to individuals with ACS has an effect on respiratory rate.

H1-4: Acupressure applied to individuals with ACS has an effect on pain levels. H1-5: Acupressure applied to individuals with ACS has an effect on anxiety levels.

H1-6: Acupressure applied to individuals with ACS has an effect on cortisol levels.

H1-7: Acupressure applied to individuals with ACS has an effect on ECG changes.

Conditions

  • Acute Coronary Syndrome
  • Nursing

Interventions

OTHER

acupressure

* First follow-up (first 0-30 minutes of admission): Participants received routine care and treatment within the first 0-30 minutes of admission, in accordance with hospital protocol. * Second follow-up (6 hours after the CAG procedure): After the coronary angiography procedure was completed (after the sandbag was removed), the first acupressure application was performed on individuals whose vital signs were within the normal range. * Third follow-up (12 hours after the CAG procedure): Approximately 12 hours after the coronary angiography procedure, the second acupressure application was performed on individuals. * Fourth follow-up (Cortisol measurement): The fourth follow-up was conducted at 8:00 a.m. (sunrise) to determine cortisol levels. Physiological parameters were evaluated, and a venous blood sample was taken to determine cortisol levels.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Principal Investigators

  • aynur açıkgöz, PhD student · Abant Izzet Baysal University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2025-04-01
Completion
2025-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06300294 on ClinicalTrials.gov